Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523622 · ClinicalTrials.gov registry record · NA
Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
A NA study of Glaucoma, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05523622: Recruiting NA study of Glaucoma, sponsored by State University of New York at Buffalo.
NCT05523622 is a NA study of Glaucoma that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 300 participants, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05523622, a NA study of Glaucoma, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.
Primary Outcome
pressure inside the eye
Conditions Studied
Interventions
- DEVICE Tono-Vera tonometer
- DEVICE Goldman Applanation Tonometry
Study Locations (1)
New York
- Ross Eye Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05523622 shows while recruiting
NCT05523622 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Tono-Vera tonometer is the first listed.
NCT05523622 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05523622 about?
NCT05523622 is a clinical study titled "Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices". We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.
What is the current status of trial NCT05523622?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-08-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05523622 study?
This clinical trial studies the following conditions: Glaucoma.
What interventions are being tested in trial NCT05523622?
The interventions under investigation include: Tono-Vera tonometer (DEVICE), Goldman Applanation Tonometry (DEVICE).
Who is sponsoring clinical trial NCT05523622?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05523622 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05523622's enrollment target sits among peer trials
300 17th of 92 higher than 75 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI